Evaluation of hypolipidemic effect of stem part of Berberis aristata in Type 2 diabetes mellitus patients as add on therapy

Journal Title: National Journal of Physiology, Pharmacy and Pharmacology - Year 2017, Vol 7, Issue 11

Abstract

Background: Diabetes mellitus (DM) is one of the oldest common metabolic disorders characterized by hyperglycemia, hyperlipidemia, negative nitrogen balance, and ketonemia. It is a one of the most important pathological conditions associated with dyslipidemia that affects the whole body system. Several types of DM exist and result by a complex interaction of genes and drugs, gestational diabetes, environmental factors such as stress and sedentary lifestyle choices. DM is the leading cause of end-stage renal disease, coronary artery disease, cerebrovascular disease, nontraumatic lower extremity amputations, and adult blindness. Aims and Objectives: This study was conducted to evaluate the hypolipidemic effect of stem part of Berberis aristata in patients of Type 2 DM with dyslipidemia as add on therapy. Materials and Methods: A prospective randomized open parallel group study was conducted in total 90 patients having high fasting blood sugar (FBS) and dyslipidemia of either sex in the age group of 30-60 years attending of outpatient/indoor Department of Medicine of Muzaffarnagar Medical College and Hospital, Muzaffarnagar, Uttar Pradesh, India. A total of 103 each Group 1 (N = 30) was taken as control while Group 2 (N = 30) and Group 3 (N = 30) was taken as study group who had received 1.5 and 3 g of B. aristata, respectively, as add on therapy along with their conventional antidiabetic and antihyperlipidemic (in certain number of patients) treatment. During the study, 13 patients (8 male and 5 female) did not complete the study and reason of premature withdrawal included protocol violation. Results: In our study, there were a statistically a highly significant improvement and stabilization of glycemic control in test Groups 2 and 3 when compared with control group (P < 0.01). In Groups 2 and 3, reduction of FBS level from 1 month onward. The mean high density lipoprotein level improved significantly in the Group 2 (P < 0.01) and highly significantly in Group 3 (P < 0.001) as compared to control. The mean total cholesterol level decreased no significantly in the Group 2 (P > 0.05) and highly significant in Group 3 (P < 0.001) as compared to control. The mean triglyceride level decreased highly significantly in the Group 2 and Group 3 (P < 0.001) as compared to control. The mean low density lipoprotein level decreased highly significant in the Group 2 and Group 3 (P < 0.001) as compared to control. Conclusion: It can be concluded that B. aristata as an add on therapy in Type 2 DM patients has a beneficial role with regard to the hyperglycemia and dyslipidemia very safe as no major side effects were observed affecting morbidity and mortality. Hence, B. aristata as an add on therapy could represent a good treatment option before initiating insulin and hypolipidemic therapy in diabetic patient with suboptional glycemic and lipideimic control to avoid unwanted adverse effects and can cut down cost of treatment.

Authors and Affiliations

Rajeev Kumar Sharma, Bhawana Sharma, Meenakshi Jindal, Arvind Kumar Gupta, Ramesh Kunwar, Suman Lata, Awadhesh Kumar Yadav

Keywords

Related Articles

Antibacterial activity test of dayak onions (Eleutherine palmifolia L. Merr.) ethanolic extract against Shigella dysenteriae ATCC 13313

Background: Acute bloody diarrhea, which is also called dysentery, is damaged of the intestinal mucosa, sepsis, and malnutrition. Shigella bacteria cause 50% of cases of dysentery; it is due to its ability to produce shi...

&nbsp;Influence of nutrition and socioeconomic status on intellectual development in school children

&nbsp;Background: The nutritional adequacy is one of the determinants of quality of human resources everywhere. Malnutrition is the root cause for the death of 6 million children each year in developing countries. Nutri...

Study of psychological predictors and sleep quality in different grades of premenstrual syndrome

Background: Premenstrual syndrome (PMS) is a recurrent, cluster of symptoms and signs that develop during the 10 days before the onset of menses and subside with the onset of menstruation. It is known to affect the women...

Self-medication practices among 2nd year medical students in a rural medical college of Telangana state

Background: Self-medication is a part of self-care, hence responsible use of drugs by physician is vital to prevent their acute and chronic adverse effects. People take medicines with their previous experiences and old p...

Detection of blaIMP gene encoding metallo-beta-lactamase resistance among clinical isolates of Pseudomonas aeruginosa

Background: In recent decades, Pseudomonas aeruginosa has emerged as a multidrug-resistant bacteria by acquiring intrinsic resistance to a number of antimicrobial agents by uses distinctive resistant mechanisms to all th...

Download PDF file
  • EP ID EP292064
  • DOI 10.5455/njppp.2017.7.0517510062017
  • Views 62
  • Downloads 0

How To Cite

Rajeev Kumar Sharma, Bhawana Sharma, Meenakshi Jindal, Arvind Kumar Gupta, Ramesh Kunwar, Suman Lata, Awadhesh Kumar Yadav (2017). Evaluation of hypolipidemic effect of stem part of Berberis aristata in Type 2 diabetes mellitus patients as add on therapy. National Journal of Physiology, Pharmacy and Pharmacology, 7(11), 1159-1169. https://www.europub.co.uk/articles/-A-292064